Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions

BackgroundCorreolide, a nortriterpene isolated from the Costa Rican tree Spachea correa, is a novel immunosuppressant, which blocks Kv1.3 channels in human T lymphocytes. Earlier mutational studies suggest that correolide binds in the channel pore. Correolide has several nucleophilic groups, but the pore-lining helices in Kv1.3 are predominantly hydrophobic raising questions about the nature of correolide-channel interactions.ResultsWe employed the method of Monte Carlo (MC) with energy minimization to search for optimal complexes of correolide in Kv1.2-based models of the open Kv1.3 with potassium binding sites 2/4 or 1/3/5 loaded with K+ ions. The energy was MC-minimized from many randomly generated starting positions and orientations of the ligand. In all the predicted low-energy complexes, oxygen atoms of correolide chelate a K+ ion. Correolide-sensing residues known from mutational analysis along with the ligand-bound K+ ion provide major contributions to the ligand-binding energy. Deficiency of K+ ions in the selectivity filter of C-type inactivated Kv1.3 would stabilize K+-bound correolide in the inner pore.ConclusionOur study explains the paradox that cationic and nucleophilic ligands bind to the same region in the inner pore of K+ channels and suggests that a K+ ion is an important determinant of the correolide receptor and possibly receptors of other nucleophilic blockers of the inner pore of K+ channels.

[1]  E. Campbell,et al.  Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K+ Channel , 2005, Science.

[2]  M. Karplus,et al.  Effective energy function for proteins in solution , 1999, Proteins.

[3]  V. Ananthanarayanan,et al.  Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists. , 2001, Archives of biochemistry and biophysics.

[4]  B. Zhorov,et al.  KvAP-based model of the pore region of shaker potassium channel is consistent with cadmium- and ligand-binding experiments. , 2005, Biophysical journal.

[5]  P. Bradley,et al.  Toward High-Resolution de Novo Structure Prediction for Small Proteins , 2005, Science.

[6]  R. Aldrich,et al.  A Mutation in S6 of Shaker Potassium Channels Decreases the K+ Affinity of an Ion Binding Site Revealing Ion–Ion Interactions in the Pore , 1998, The Journal of general physiology.

[7]  V. Ananthanarayanan Peptide hormones, neurotransmitters, and drugs as Ca2+ ionophores: implications for signal transduction. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[8]  W. Welsh,et al.  Structural Model Reveals Key Interactions in the Assembly of the Pregnane X Receptor/Corepressor Complex , 2006, Molecular Pharmacology.

[9]  F. Ashcroft,et al.  Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State , 2003, Science.

[10]  K. Takano ON SOLUTION OF , 1983 .

[11]  B. Zhorov,et al.  Potassium, sodium, calcium and glutamate‐gated channels: pore architecture and ligand action , 2004, Journal of neurochemistry.

[12]  G. Kaczorowski,et al.  Binding of Correolide to the Kv1.3 Potassium Channel: Characterization of the Binding Domain by Site-Directed Mutagenesis† , 2001 .

[13]  P. Focia,et al.  Structural basis of TEA blockade in a model potassium channel , 2005, Nature Structural &Molecular Biology.

[14]  O. Hensens,et al.  Potent nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae , 1998 .

[15]  O. Hensens,et al.  Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. , 1999, Biochemistry.

[16]  J. Liu,et al.  Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction. , 1999, The Journal of biological chemistry.

[17]  V. Ananthanarayanan,et al.  Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand. , 1996, Biophysical journal.

[18]  G. Yellen,et al.  Intracellular gate opening in Shaker K+ channels defined by high-affinity metal bridges , 2004, Nature.

[19]  P. Kollman,et al.  An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.

[20]  Youxing Jiang,et al.  Crystal structure and mechanism of a calcium-gated potassium channel , 2002, Nature.

[21]  G. Kaczorowski,et al.  Potent Kv1.3 inhibitors from correolide-modification of the C18 position. , 2005, Bioorganic & medicinal chemistry letters.

[22]  G. Yellen,et al.  The Activation Gate of a Voltage-Gated K+ Channel Can Be Trapped in the Open State by an Intersubunit Metal Bridge , 1998, Neuron.

[23]  P. Bregestovski,et al.  Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships. , 2000, Biophysical journal.

[24]  Yi Liu,et al.  Blocker protection in the pore of a voltage-gated K+ channel and its structural implications , 2000, Nature.

[25]  B. Zhorov,et al.  Atomic determinants of state‐dependent block of sodium channels by charged local anesthetics and benzocaine , 2006, FEBS letters.

[26]  B. Zhorov,et al.  Sodium channel activators: Model of binding inside the pore and a possible mechanism of action , 2005, FEBS Letters.

[27]  R. MacKinnon,et al.  The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. , 2003, Journal of molecular biology.

[28]  G. Kaczorowski,et al.  Pharmacology of voltage-gated and calcium-activated potassium channels. , 1999, Current opinion in chemical biology.

[29]  R. MacKinnon,et al.  Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors , 2001, Nature.

[30]  S. Grissmer,et al.  Interaction of d-Tubocurarine with Potassium Channels: Molecular Modeling and Ligand Binding , 2006, Molecular Pharmacology.

[31]  J. Matkó K+ channels and T-cell synapses: the molecular background for efficient immunomodulation is shaping up. , 2003, Trends in pharmacological sciences.

[32]  H. Scheraga,et al.  Monte Carlo-minimization approach to the multiple-minima problem in protein folding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Kaczorowski,et al.  Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis. , 2001, Biochemistry.

[34]  J. Ruppersberg Ion Channels in Excitable Membranes , 1996 .

[35]  O. McManus,et al.  Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. , 1999, Cellular immunology.

[36]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[37]  Jane Mitchell,et al.  How Batrachotoxin Modifies the Sodium Channel Permeation Pathway: Computer Modeling and Site-Directed Mutagenesis , 2006, Molecular Pharmacology.

[38]  M. Cadene,et al.  X-ray structure of a voltage-dependent K+ channel , 2003, Nature.

[39]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.